CD20 expression: A risk stratification factor for newly diagnosed multiple myeloma with t(11;14)

OBJECTIVE: Translocation (11;14) is one of the most frequent recurrent cytogenetic abnormalities in multiple myeloma (MM), while its clinical prognostic value remains controversial. CD20 expression is uncommon in MM while strongly associated with t(11;14). This study aimed to investigate whether CD2...

Descripción completa

Detalles Bibliográficos
Autores principales: Jian, Yuan, Zhang, Zhiyao, Zhou, Huixing, Yang, Guangzhong, Geng, Chuanying, Wang, Huijuan, Gao, Wen, Chen, Wenming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752036/
https://www.ncbi.nlm.nih.gov/pubmed/36531062
http://dx.doi.org/10.3389/fonc.2022.1061438

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752036/
https://www.ncbi.nlm.nih.gov/pubmed/36531062
http://dx.doi.org/10.3389/fonc.2022.1061438

Ejemplares similares